Option chain shows key data for Mustang Bio's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Mustang Bio.

Mustang Bio (NASDAQ:MBIO) Stock, Option Chain

Mustang Bio

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

wall street christmas unsplash

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

AIFF

HEES

MBIO

NMHI

PHIO

Dow Gains Over 200 Points; Signet Jewelers Shares Plunge

Crude-oil-4-logo

Intraday Update

Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher

wall-street-4847634_1280

ATPC

Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In December

Mustang Bio Inc

Financing

Press Releases

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

Health Care

General

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

Mustang Bio Receives Positive Listing Determination from Nasdaq

Mustang Bio Announces Reverse Stock Split

IPOs

Mustang Bio Announces Pricing of $8 Million Public Offering

Mustang Bio Announces Closing of $8 Million Public Offering

Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

FBIO

Aditxt

AEON Biopharma, Inc. Class A Common Stock

AEON Biopharma

Aptevo Therapeutics

180 Life Sciences

Azitra

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Galecto

Pasithea Therapeutics Corp. - Common Stock

Pasithea Therapeutics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Matinas Biopharma Holdings, Inc. Common Stock

Matinas BioPharma Hldgs

Oragenics

Organovo Holdings

Palisade Bio

Plus Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Sunshine Biopharma

Synaptogenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Alaunos Therapeutics, Inc. - Common Stock

Alaunos Therapeutics

Theriva Biologics

Xenetic Biosciences

HC Wainwright & Co.

Cantor Fitzgerald

BTIG

Comments

Mustang Bio

Mustang Bio (MBIO) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga